Quinazolinone inhibitors of cgmp phosphodiesterase

Details Quinazolinone inhibitors of cgmp phosphodiesterase Quinazolinone inhibitors of cgmp phosphodiesterase

A - Human Necessities

61

K

A61K 31/505 (2006.01) A61K 31/535 (2006.01) A61K 31/55 (2006.01) C07D 487/04 (2006.01)

Patent

CA 2334970

Novel quinazolinone compounds, methods of using such compounds in the treatment of cGMP-associated conditions such as erectile dysfunction, and pharmaceutical compositions containing such compounds.

Nouveaux composés quinazolinone, procédés d'utilisation desdits composés dans le traitement d'états pathologiques associés à l'acide guanosine-3'5'-monosphosphate cyclique (cGMP), tels que les troubles de l'érection, et compositions pharmaceutiques contenant lesdits composés.

Affiliated with

Also associated with

Rating

Quinazolinone inhibitors of cgmp phosphodiesterase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinazolinone inhibitors of cgmp phosphodiesterase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazolinone inhibitors of cgmp phosphodiesterase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1362932